The global changing pattern of the oral manifestations of HIV
- PMID: 32862536
- DOI: 10.1111/odi.13469
The global changing pattern of the oral manifestations of HIV
Abstract
The significance of the oral manifestations of HIV has been widely recognised since the start of the epidemic. It is estimated that more than 38 million people are living with HIV currently, with more than a third presenting with oral manifestations. Access to optimum clinical management and effective treatment in resource-rich countries has led to a remarkable decrease in some of the oral manifestations in the HIV population but this is not mirrored in developing countries, where most HIV-positive patients reside. In this paper, a review of the literature since the start of the HIV infection in different parts of the world is presented to highlight the current significance of the oral conditions in this population. Oral candidiasis was repeatedly reported as the most encountered oral manifestation of HIV in different countries, including in studies on groups on anti-retroviral therapy. Over time salivary gland disease was reported less in developed countries but was encountered more in developing countries. There is evidence to show that the prevalence of oral warts increased with the establishment of anti-retroviral therapy. A review of the worldwide prevalence of HIV-related oral conditions indicates that except for oral hairy leucoplakia, the prevalence of all other nine commonly reported oral conditions remained the same or increased over time. Oral opportunistic infections in HIV-infected patients are an ongoing clinical burden mainly in developing countries. Maintaining research in the subject and improving access to HIV treatment will help address the oral health inequalities around the world.
Keywords: Global; candidiasis; oral hairy leucoplakia; oral health inequity; oral warts; salivary gland disease.
© 2020 The Authors. Oral Diseases published by John Wiley & Sons Ltd.
References
REFERENCES
-
- Aggarwal, R., Ringold, S., Khanna, D., Neogi, T., Johnson, S. R., Miller, A., … Feldman, B. M. (2015). Distinctions between diagnostic and classification criteria? Arthritis Care & Research, 67(7), 891-897. https://doi.org/10.1002/acr.22583
-
- Anaya-Saavedra, G., Flores-Moreno, B., Garcia-Carranca, A., Irigoyen- Camacho, E., Guido-Jimenez, M., & Ramirez-Amador, V. (2013). HPV oral lesions in HIV-infected patients: The impact of long-term HAART. Journal of Oral Pathology and Medicine, 42(6), 443-449. https://doi.org/10.1111/jop.12032
-
- Arendorf, T. M., Bredekamp, B., Cloete, C., Wood, R., & O’Keefe, E. (1997). Intergroup comparisons of oral lesions in HIV-positive South Africans. Oral Diseases, 3(Suppl 1), S54-S57. https://doi.org/10.1111/j.1601-0825.1997.tb00375.x
-
- Barone, R., Ficarra, G., Gaglioti, D., Orsi, A., & Mazzotta, F. (1990). Prevalence of oral lesions among HIV-infected intravenous drug abusers and other risk groups. Oral Surgery, Oral Medicine, Oral Pathology, 69(2), 169-173. https://doi.org/10.1016/0030-4220(90)90322-J
-
- Berberi, A., & Noujeim, Z. (2015). Epidemiology and relationships between CD4+ counts and oral lesions among 50 patients infected with human immunodeficiency virus. Journal of International Oral Health, 7(1), 18-21.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical